# Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty

> **NCT06244498** · — · COMPLETED · sponsor: **Piotr Biega** · enrollment: 110 (actual)

## Conditions studied

- Metastases to Bone

## Interventions

- **DRUG:** Tranexamic acid injection

## Key facts

- **NCT ID:** NCT06244498
- **Lead sponsor:** Piotr Biega
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06244498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06244498, "Tranexamic Acid After Pathological Fracture Treated With Modular Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06244498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*